Literature DB >> 1883916

Quantitative characterization of the intrinsic ligand-binding affinity of the interleukin 2 receptor beta chain and its modulation by the alpha chain and a second affinity-modulating element.

G E Ringheim1, B D Freimark, R J Robb.   

Abstract

The interleukin 2 receptor is a multisubunit receptor known to consist of at least two IL-2 binding subunits, alpha and beta. We report here kinetic evidence defining the contribution of an affinity-modulating element(s) intimately involved in modulation of the ligand-binding affinity of the beta chain and alpha/beta complex. The principal effect of this modulating element on the beta chain is to slow the dissociation of IL-2 more than 150-fold and thus raise its low intrinsic IL-2 binding affinity (Kd = 70 nM) as defined in transfected fibroblast cells to the level observed in lymphoid cells (Kd = 1.2 nM). The alpha subunit also increases the ligand-binding affinity of the beta chain, although in this case principally by increasing the association rate constant more than 1200-fold. The additional effect of the affinity-modulating element on the alpha/beta complex is minimal with regards to the equilibrium binding affinity. It does, however, have a detectable 14-fold effect on slowing the IL-2 dissociation rate. The existence of multiple forms of IL-2 receptor complexes with widely varying ligand affinities and dissociation rates illustrates the need for careful evaluation of binding data in studies of receptor subunit composition and reconstitution.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883916

Source DB:  PubMed          Journal:  Lymphokine Cytokine Res        ISSN: 1056-5477


  10 in total

Review 1.  X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis.

Authors:  N L Farner; S D Voss; P M Sondel
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

2.  Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain.

Authors:  S D Voss; T P Leary; P M Sondel; R J Robb
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

3.  Functional interleukin-2 receptors on intestinal epithelial cells.

Authors:  C Ciacci; Y R Mahida; A Dignass; M Koizumi; D K Podolsky
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Cooperative interactions between the interleukin 2 receptor alpha and beta chains alter the interleukin 2-binding affinity of the receptor subunits.

Authors:  E Roessler; A Grant; G Ju; M Tsudo; K Sugamura; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

5.  Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement.

Authors:  N Kruse; H P Tony; W Sebald
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

6.  Receptor antagonist and selective agonist derivatives of mouse interleukin-2.

Authors:  S M Zurawski; G Zurawski
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

7.  The amino-terminal helix of GM-CSF and IL-5 governs high affinity binding to their receptors.

Authors:  A B Shanafelt; A Miyajima; T Kitamura; R A Kastelein
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

8.  Definition and spatial location of mouse interleukin-2 residues that interact with its heterotrimeric receptor.

Authors:  S M Zurawski; F Vega; E L Doyle; B Huyghe; K Flaherty; D B McKay; G Zurawski
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

9.  Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.

Authors:  S D Voss; P M Sondel; R J Robb
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

Review 10.  Monoclonal antibody therapy and renal transplantation: focus on adverse effects.

Authors:  Gianluigi Zaza; Paola Tomei; Simona Granata; Luigino Boschiero; Antonio Lupo
Journal:  Toxins (Basel)       Date:  2014-02-28       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.